CONTENTS
· Letter from the Chairs
· Faculty
· Scientific Agenda
· Continuing Medical Education
· Target Audience
· Objectives
· Registration
· General Information
· Hotel Accommodations
· Congress Support

Dear Colleagues:

We are pleased to invite you to attend the 5th European Congress: Perspectives in Gynecologic Oncology, to be held 18-19 January 2008 in Cannes, France.

This year’s meeting promises to be an exciting educational event where case presentations and expert discussion led by key opinion leaders in the field will provide the foundation of the program content for practitioners involved in the diagnosis and management of gynecological cancers. Through this focus on case-based discussion, practical approaches to the management of cervical, endometrial and ovarian cancers can be applied to clinical practice. By the conclusion of the meeting, attendees will also be able to identify emerging therapies for gynecologic cancers and develop valuable strategies to integrate them into current disease management.

We are excited about the educational approach of the meeting this year and look forward to welcoming you in beautiful Cannes for what is sure to be a very rewarding educational and collegial experience.

Sincerely,
Andreas du Bois, MD, PhD
Peter G. Harper, MD, FRCP
Stanley B. Kaye, MD
Congress Chairs

Nicoletta Colombo, MD
University of Milan-Bicocca
European Institute of Oncology
Milano, Italy

Andreas du Bois, MD, PhD
Dr. Horst Schmidt Klinik
Wiesbaden, Germany

Stefano Greggi MD, PhD
National Cancer Institute
Fondazione Pascale
Naples, Italy

Peter G. Harper, MD, FRCP
Guy’s and St. Thomas’ Hospital
London, United Kingdom

Phillip Harter, MD
Dr. Horst Schmidt Klinik
Wiesbaden, Germany

Thomas Högberg, MD, PhD
University Hospital
Linkoping, Sweden

Stanley B. Kaye, MD
The Royal Marsden Hospital
Sutton, United Kingdom

Henry C. Kitchener, MD, FRCOG
The University of Manchester
Manchester, United Kingdom

David H. Moore, MD
Gynecologic Oncology of Indiana
Indianapolis, Indiana, United States

Jacobus Pfisterer, MD, PhD
University Hospital Schleswig-Holstein
Kiel, Germany

Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire
Hotel-Dieu
Paris, France

Jalid Sehouli, MD
Charité University Hospital
Berlin, Germany

Alexandra Taylor, MD
Imperial College Healthcare Trust
London, United Kingdom

Gillian Thomas, MD
University of Toronto
Toronto, Ontario, Canada

Ate G.J. van der Zee, MD
University of Groningen
Groningen, The Netherlands

Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Friday, 18 January 2008

Session I: Cervical cancer
Moderator: Ignace Vergote, MD, PhD

13:00
Welcome and introduction

13:10 HPV vaccines and implications for cervical cancer screening
Henry C. Kitchener, MD, FRCOG

13:35 Surgical staging of cervical cancer
Speaker invited

14:00
Case presentation and expert discussion FIGO IB2: Which patients are suitable for surgery and which patients should receive radiotherapy?
Radiation Oncologist’s perspective: Gillian Thomas, MD
Surgeon’s perspective: Speaker invited

14:45
Case presentation and expert discussion
Metastatic disease: Management of a central recurrence with bladder infiltration and suspect pelvic lymph nodes
Surgeon’s perspective: Stefano Greggi MD, PhD
Medical Oncologist’s perspective: David H. Moore, MD

15:30
Break

Session II: Endometrial cancer and vulvar cancer
Moderator: Stanley B. Kaye, MD

15:50
Defining intermediate and high-risk prognosis: Classical methods and molecular insights
Thomas Högberg, MD, PhD

16:10
Case presentation and expert discussion
Early stage high risk management options: Adjuvant radiotherapy vs. chemotherapy vs. both
Radiotherapy advocate: Alexandra Taylor, MD
Chemotherapy advocate: Thomas Högberg, MD, PhD

16:55
Case presentation and expert discussion
FIGO IIIC: Three drug regimen vs. other management options
Three drug option advocate: Jalid Sehouli, MD
Other management options advocate: Speaker invited

17:40
Update on the management of vulvar cancer
Ate G.J. van der Zee, MD

18:00
Adjourn

Saturday, 19 January 2008

Session III: Ovarian neoplasm I
Moderator: Peter G. Harper, MD, FRCP

09:00
Welcome and introduction

09:10
Diagnosis: Predicting outcome and operability
Speaker invited

09:35
Case presentation and expert discussion
FIGO stage III: Timing of surgery
Surgeon’s perspective: Andreas du Bois, MD, PhD
Medical Oncologist’s perspective: Speaker invited

10:20
First line therapy: Overview of new agents and ongoing clinical trials
Ignace Vergote, MD, PhD

Keynote Address
10:45
Emerging targeted therapies for ovarian cancer
Stanley B. Kaye, MD

11:45
Lunch

Session IV: Ovarian neoplasm II
Moderator: Andreas du Bois, MD, PhD

13:45
Optimal management of recurrent ovarian cancer: Role of the treatment free interval
Eric Pujade-Lauraine, MD, PhD

14:10
Case presentation and expert discussion
Management of a 9 month relapse
Non-platinum perspective: Nicoletta Colombo, MD
Platinum perspective: Jacobus Pfisterer, MD, PhD

14:55
Case presentation and expert discussion
Role of surgery: A patient with recurrence in 2 sites
Surgeon’s perspective: Phillip Harter, MD
Medical Oncologist’s perspective: Peter G. Harper, MD, FRCP

15:40
Management of borderline tumors
Speaker invited

16:05
Closing statements

16:15
Adjourn

Imedex^®, LLC is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.”

Perspectives in Gynecologic Oncology is designated for a maximum of 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”

EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.

This activity is intended for gynecologists, oncologists, radiation therapists, pathologists, and other practitioners involved in the diagnosis and management of gynecologic cancers including ovarian, endometrial and cervical cancers. No specific knowledge or skills other than a basic training in one of the above-mentioned disciplines is required for successful participation in the activity.

After successfully completing this educational activity, participants should be able to:

• Assess the impact of recently available human papilloma virus (HPV) vaccines on the prevention and screening of cervical cancer
  
• Develop a practical, case-based approach to management of early-stage cervical cancer and advanced disease
  
• Apply advances and strategies in staging and management of endometrial cancer to clinical practice
  
• Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation
  
• Formulate the best management strategies for recurrent ovarian cancer
  
• Identify emerging therapies for gynecologic cancers, and develop strategies to integrate them into current disease management
  

Click here to register online.

REGISTRATION FEES
Physicians
Discounted . . . . . . . . . . . . . . . . € 249
(payment received by 26 November 2007)

Regular . . . . . . . . . . . . . . . . . . € 349
(payment received by 10 January 2008)

Full/Onsite . . . . . . . . . . . . . . . . € 449
(payment received after 10 January 2008)

Nurses/Residents/Students
Regular . . . . . . . . . . . . . . . . . . . € 99
(proof of eligibility must accompany registration)

To Register: You may register online by 10 January 2008 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the Congress.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than 10 January 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add € 50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: 5th European Congress: Perspectives in Gynecologic Oncology/317. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, Congress materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 10 January 2008. The amount of registration fees remitted, minus a € 90 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 10 January 2008.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this activity should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event content is subject to change without notice.

Registration Hours
The Registration and Information Desk at the Intercontinental Carlton Cannes will be staffed:

Friday, 18 January 2008 . . . . . . . . . . 11:00 - 18:00
Saturday, 19 January 2008 . . . . . . . . 08:00 - 16:00

Italian Participants
Fargo International Meetings & Conventions SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:

Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

InterContinental Carlton Cannes
58, Bd. La Croisette Bp 155
Cannes, 06414 France
Tel.: +33 4 9306 4006
Fax: +33 4 9306 4025
www.ichotelsgroup.com

The hotel InterContinental Carlton Cannes is the most legendary 4-star deluxe hotel in Cannes. Its façade, registered as a “Historical Monument”, became a reference point in the city landscape of the French Riviera, and is recognized all over the world. The Carlton, with its unique waterfront location offers unrivalled views over the bay of Cannes. The Carlton is ideally located in the heart of La Croisette and 30 minutes from Nice International Airport. The 338 guest rooms including 36 renovated suites boast every comfort of a palace. The Carlton hotel is a mix of tradition, know-how, and pleasure: 14 prestigious meeting rooms, a historic landmark, a private beach, a sunny terrace, and a highly qualified staff to welcome you. The InterContinental Carlton is also the Carlton Brasserie, the beach restaurant, the famous Bar des Célébrités and the Chef Laurent Bunel, who offers you his Provençal dishes.

For the convenience of attendees, a limited number of rooms have been reserved until 3 January 2008 at a discounted rate of c150 single occupancy or € 175 double occupancy, plus VAT and city tax currently at € 1.30 per person per night. This rate is not guaranteed outside the Congress dates or after 3 January 2008.

To reserve your room please contact the InterContinental Carlton Cannes reservations department at +33 4 9306 4006 or visit the hotel’s website at www.ichotelsgroup.com. To receive the group rate, callers must identify themselves as being with the 5th European Congress: Perspectives in Gynecologic Oncology group. Reservation requests received after 3 January 2008 may not be guaranteed the group rate.

          4325 Alexander Drive
          Alpharetta, GA 30022-3740 USA
          Tel.: +1 (770) 751 7332
          Fax: +1 (770) 751 7334
          Email: meetings@imedex.com
          Web: www.imedex.com